header logo image


Page 534«..1020..533534535536..540550..»

Did Life Emerge in the Primordial Soup via DNA or RNA? Surprising Answer From New Research – SciTechDaily

June 9th, 2020 9:44 am

Scientists have long debated which genetic information carrier DNA or RNA started life on Earth, but a new study suggests life could have begun with a bit of both. The research, led by scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB), in Cambridge, shows for the first time how some of the building blocks of both DNA and RNA could have spontaneously formed and co-existed in the primordial soup on Earth.

The work challenges one of the leading hypotheses for the advent of life the RNA world theory, which arose in the 60s and has gained wide acceptance.

Today, all known living organisms use the same genetic molecules called nucleic acids to store information. There are two sorts of nucleic acids: DNA and RNA. DNA encodes instructions in genes. Genes are turned into messages using RNA, which carries instructions to make proteins. Proteins can make structures and act as molecular machines.

In the RNA world theory, life started with RNA molecules, which can both store instructions and can act as a modest machine, potentially enabling them to self-replicate. It proposes that through evolution, life in the RNA world gave way to the era of DNA and proteins, because DNA is more stable and durable than RNA.

In the current study, published in Nature, the researchers simulated the conditions on a primordial rocky Earth with shallow ponds in the lab. They dissolved chemicals that form RNA in water, then dried them out and heated them, then they simulated the early suns rays by exposing them to UV radiation.

In this recreation of early Earth geochemistry, intermediates in the synthesis of two of the building blocks of RNA were simultaneously also converted into two of the building blocks of DNA.

It is the first demonstration that reasonable amounts of a genetic alphabet made up of four building blocks, two for RNA and two for DNA potentially sufficient to have encoded early life, which was far less complex than life today may have been available on the primordial Earth.

Professor John Sutherland from the MRC Laboratory of Molecular Biology, who led the work, says: The RNA world hypothesis suggests that life began with RNA, before a genetic takeover occurred involving primitive biosynthetic machinery and natural selection to result in DNA.

Our work suggests that in conditions consistent with shallow primordial ponds and rivulets there was a mixed genetic system with RNA and DNA building blocks co-existing at the dawn of life. This fulfills what many people think is a key precondition for the spontaneous emergence of life on Earth.

The teams experiments to simulate early Earth geochemistry showed that four of the building blocks for DNA and RNA can arise from the same reagents and conditions. They produced cytidine and uridine, two of the building blocks of RNA, and deoxyadenosine, which is one of those of DNA. Deoxyadenosine was partly converted to deoxyinosine, which can take the role of another DNA building block.

They believe that these four building blocks may have coexisted before life evolved and were the beginnings of a primitive genetic alphabet.

Professor Sutherland adds: The nucleic acids, RNA and DNA, are clearly related and this work suggests that they both derive from a hybrid ancestor, rather than one preceding the other.

Since genetic information always flows from nucleic acids to proteins, and never in reverse a principle called the central dogma of molecular biology by Francis Crick we now need to uncover how the information which can be stored and purveyed by these nucleic acids could have been first used to make to proteins.

Understanding the chemical origins of life is a fundamental aspect of natural science, and can inform the design of future synthetic biology.

Dr. Megan Dowie, head of molecular and cellular medicine at the MRC commented: This study shows that blue skies research can reveal fascinating insights into how the very beginnings of life may have emerged, and demonstrates the importance of supporting fundamental research. These underpinning discoveries in the life sciences could enable exciting future strategies for artificial biology.

Reference: Selective prebiotic formation of RNA pyrimidine and DNA purine nucleosides by Jianfeng Xu, Vclav Chmela, Nicholas J. Green, David A. Russell, Mikoaj J. Janicki, Robert W. Gra, Rafa Szabla, Andrew D. Bond & John D. Sutherland,3 June 2020, Nature.DOI: 10.1038/s41586-020-2330-9

See the article here:
Did Life Emerge in the Primordial Soup via DNA or RNA? Surprising Answer From New Research - SciTechDaily

Read More...

Autobahn Therapeutics Raises $76M in Series B Financing – FinSMEs

June 9th, 2020 9:44 am

Autobahn Therapeutics, a San Diego, CA-based developer of regenerative medicines to restore hope for people affected by CNS disorders, completed a $76m Series B funding round.

The round was co-led by Arch Venture Partners and Cowen Healthcare Investments, with participation from BVF Partners L.P., Biogen, Bristol Myers Squibb, Pfizer Ventures, Invus, Section 32, Samsara BioCapital and Alexandria Venture Investments.

The company intends to use the funds to advance its lead program candidate, ABX-002, a thyroid hormone receptor beta agonist therapy for the treatment of multiple sclerosis (MS) and adrenomyeloneuropathy (AMN), a rare genetic disorder, and a portfolio of transformational CNS programs leveraging its brain-targeting chemistry platform.

Led by Kevin Finney, chairman and chief executive officer, Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders. The company is leveraging a deep understanding of validated human biology coupled with its brain-targeting chemistry platform to develop thyroid hormone receptor beta agonist therapies that harness the regenerative power of the human body. The pipeline is led by ABX-002 for the treatment of multiple sclerosis and adrenomyeloneuropathy (AMN), a rare genetic disorder.

The company has built a team of experts in thyromimetics, drug discovery and development, clinical operations, and corporate and business development:

Kevin Finney, chairman of the board of directors and chief executive officer;

Keith Lenden, co-founder, president and chief operating officer;

Brian Stearns, Ph.D., chief scientific officer;

Chan Beals, M.D., Ph.D., senior vice president of translational medicine;

Christine Maurer, senior vice president of development operations and program management;

John Borkholder, J.D., general counsel and senior vice president of administration; and

Thomas Scanlan, Ph.D., co-founder and senior advisor to Autobahn, and professor of Chemical Physiology and Biochemistry, Oregon Health & Science University.

FinSMEs

09/06/2020

Continued here:
Autobahn Therapeutics Raises $76M in Series B Financing - FinSMEs

Read More...

Precision Medicine and Diagnostics Expert Hakan Sakul, Ph.D., of Pfizer Joins the Progentec Board of Directors – PRNewswire

June 9th, 2020 9:43 am

OKLAHOMA CITY, June 3, 2020 /PRNewswire/ --Progentec, a leader in next-gen diagnostics and digital technologies for the management of autoimmune diseases, announced today that Hakan Sakul, Ph.D., Vice President and Head of Diagnostics at Pfizer, has joined the Progentec Board of Directors. Dr. Sakul has a distinguished track record in the development and commercialization of companion diagnostics, precision medicine, and pharmacogenomics. His wealth of experience and knowledge will support Progentec in its mission to improve health outcomes for people living with autoimmune diseases.

"Lupus is a difficult disease to diagnose and a lab-based testing is sorely needed to confirm its diagnosis," said Dr. Sakul. "I am delighted to join Progentec's Board in this important phase of the company's diagnostics development journey."

In addition to his R&D, clinical, and product expertise, Dr. Sakul has deep experience in regulatory policy. He is currently a member of California Gov. Newsom's Precision Medicine Advisory Council, and was previously an Advisory Board member for California Gov. Brown's Precision Medicine Advisory Committee. Dr. Sakul is also on the board of directors for the Personalized Medicine Coalition and serves on Luminex Corporation's Oncology Advisory Committee.

About Progentec Diagnostics, Inc.

Progentec is committed to improving access and health outcomes for patients in therapeutic areas with a high level of unmet need by combining clinically-validated diagnostic interventions with state-of-the-art digital technologies. Through collaborations with research institutions and health practitioners around the world, Progentec is working to reduce mortality and morbidity while improving care management and service delivery for chronic health conditions.

Forward-Looking Statements:

Statements contained herein that are not historical facts are forward-looking statements that represent management's beliefs and assumptions as of the date of this news release based on currently available information. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot assure that these expectations will prove to be correct. Such statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in any forward-looking statements.

Contact:

Mohan Purushothaman

(973) 885-5242

[emailprotected]

SOURCE Progentec Diagnostics, Inc.

http://www.progentec.com

More here:
Precision Medicine and Diagnostics Expert Hakan Sakul, Ph.D., of Pfizer Joins the Progentec Board of Directors - PRNewswire

Read More...

4 Industries That’ll Thrive in the New Bull Market – Motley Fool

June 9th, 2020 9:43 am

Fasten your seatbelts, folks, because the stock market has been on one heck of an emotional roller-coaster over much of the past four months. Initially, panic and uncertainty tied to the coronavirus disease 2019 (COVID-19) pandemic sent the broad-based S&P 500 down 34% in less than five weeks. But in the subsequent 11 weeks, we've witnessed roughly 80% of this initial drop clawed back by equities, with Wall Street appearing to enter a new bull market.

Although swoons in the stock market are inevitable, history has decisively shown that opportunistic long-term investors who buy during these periods of weakness tend to make money. It's never really a question of whether you should invest when a new bull market emerges, but where you should park your capital.

Assuming a new bull market has been established, the following four industries look set to thrive (and dominate) for a long time to come.

Image source: Getty Images.

One of the bigger beneficiaries of the COVID-19 pandemic is cybersecurity. To be perfectly clear, cybersecurity was already growing at a healthy pace well before the coronavirus shut down nonessential businesses across much of the country. But with more employees being forced to work remotely than ever before, the need to secure cloud-based data is taking on added importance. Essentially, COVID-19 took an existing trend and gave it a shot of adrenaline.

Hands down, my favorite company in this space is Palo Alto Networks (NYSE:PANW), which I pegged on April 9, 2020, as one of five stocks that could be a 10-bagger (i.e., deliver 1,000%-plus returns) by 2030.

Aside from the fact that enterprise cloud demand continues to pick up, Palo Alto benefits from the fact that it's pushing subscription and support-based solutionsas opposed to hardware. Subscriptions generate much better margins than hardware, and cash flow is far more predictable as Palo Alto is unlikely to see customer churn for what's effectively a basic-need service for any business.

Over the past year, Palo Alto's subscription and support revenue has grown to account for 68% of total sales, up from approximately 62% in the prior-year quarter.

Image source: Getty Images.

Building off of cybersecurity, the hottest thing since sliced bread in the new bull market is going to be anything having to do with cloud computing. This could mean the infrastructure players that are responsible for aiding businesses in creating their cloud, platform-as-a-service providers that allow enterprises to build, manage, and deploy applications, and software-as-a-service companies, which operate and sell ready-to-use apps for businesses and consumers.

Interestingly, some of the most prominent names in the cloud space are the United States' largest publicly traded companies: Amazon (NASDAQ:AMZN) with Amazon Web Services (AWS), Microsoft with Azure, and Alphabet with Google Cloud.

I don't see how investors can't get excited about Amazon in the new bull market. Even putting aside its e-commerce dominance, AWS continues to grow at about twice the pace of its retail/ad operations, and it produces considerably better margins. With Amazon's cloud services now accounting for 13.5% of total sales in Q1 2020 and a majority of its operating income, it's no wonder Wall Street expects a near-tripling in the company's operating cash flow by 2023.

Image source: Getty Images.

The new bull market will also feature an ongoing push toward personalized medicine. By personalized medicine, I'm referring to the idea of tailoring treatment for each individual rather than offering generalized medical solutions. Most personalized medicine leans on the increased use of technology, the cloud, and innovative new devices.

For example, another 10-bagger stock I singled out in April is Livongo Health (NASDAQ:LVGO), a provider of personalized health solutions. Using mountains of collected data and artificial intelligence, Livongo sends tips to members with diabetes in order to help them make meaningful behavioral changes that result in them living longer and healthier lives. It also doesn't hurt that Livongo's solutions can potentially work hand in hand with other wireless diabetes devices (e.g., insulin pumps), meaning patients don't have to leave the comfort of their homes to convey sensitive data to their physicians.

Maybe the best thing about Livongo Health and the personalized medicine push is that it's not all talk. Livongo's Diabetes member count doubled from the prior-year quarter to more than 328,000, and it's already generated two consecutive quarters of profitability despite significant reinvestment into its solutions.

If Livongo is already turning the corner to profitability with less than 1% of U.S. diabetes market share, just imagine its potential when it expands to treat other chronic illnesses, like hypertension.

Image source: Getty Images.

Finally, look for the Internet of Things (IoT) to finally realize its full potential in the new bull market. By IoT, I'm talking about wireless devices being able to connect and communicate with one another and data centers. Examples might include a smart thermostat that learns your heating and cooling preferences to conserve energy usage in your home, or an automobile that automatically reorders a defective or soon-to-be-defective component.

It's not uncommon for Wall Street and investors to overestimate the impact of new technology and be left disappointed. This is sort of what happened with IoT stocks in the latter half of the 2010s. But with an increased reliance on work-from-home, the cloud, and even personalized medicine, the value of IoT is rising like never before.

To build off of the previous industry (personalized medicine), DexCom (NASDAQ:DXCM) is the perfect example of IoT in action. Dexcom, which happens to have a deal in place with Livongo Health, is a producer of continuous glucose monitoring devices for diabetics. DexCom's devices can provide patients with real-time blood-glucose levels, communicate with insulin pumps to administer or hold off on the administration of insulin, and aid in producing reports that can be sent to a primary care provider.

IoT has applications in virtually every industry, and the new bull market should showcase that fact.

See the original post:
4 Industries That'll Thrive in the New Bull Market - Motley Fool

Read More...

The Global Humanized Mouse Model Market is expected to grow by $ 74.72 million during 2020-2024 progressing at a CAGR of 12% during the forecast…

June 9th, 2020 9:43 am

New York, June 09, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Humanized Mouse Model Market 2020-2024" - https://www.reportlinker.com/p05048523/?utm_source=GNW Our reports on humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising focus on preventing the spread of pandemics and innovative applications. In addition, rising focus on preventing the spread of pandemics is anticipated to boost the growth of the market as well. The humanized mouse model market analysis includes product segment and geographic landscapes

The humanized mouse model market is segmented as below: By Product Genetically humanized mouse model Cell-based humanized mouse model

By Geographic Landscapes North America Europe Asia ROW

This study identifies growing adoption of personalized medicine as one of the prime reasons driving the humanized mouse model market growth during the next few years. "The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our humanized mouse model market covers the following areas: Humanized mouse model market sizing Humanized mouse model market forecast Humanized mouse model market industry analysis"

Read the full report: https://www.reportlinker.com/p05048523/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Follow this link:
The Global Humanized Mouse Model Market is expected to grow by $ 74.72 million during 2020-2024 progressing at a CAGR of 12% during the forecast...

Read More...

PREDICTIVE ONCOLOGY : Management’s Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) – marketscreener.com

June 9th, 2020 9:43 am

The following discussion and analysis should be read together with our unauditedcondensed consolidated financial statements and related notes thereto set forthin this Quarterly Report on Form 10-Q as well as our Annual Report on Form 10-Kfor the year ended December 31, 2019.This Form 10-Q contains "forward-looking statements" that indicate certain risksand uncertainties, many of which are beyond our control. Actual results coulddiffer materially and adversely from those anticipated in such forward-lookingstatements as a result of certain factors, including those set forth below andelsewhere in this report. Important factors that may cause actual results todiffer from projections include: We may not be able to continue operating without additional financing; Current negative operating cash flows; The terms of any further financing, which may be highly dilutive and may include onerous terms; Significant debt repayments due between June and September 2020, which the Company will likely need to extend or

restructure, with

associated with

pandemic, which

Our precision medicine business, conducted in our Helomics division, iscommitted to improving the effectiveness of cancer therapy using ourproprietary, multi-omic tumor profiling platform, one-of-a-kind database ofhistorical tumor data, and the power of AI to build predictive models of tumordrug response.

Contract Research Organization (CRO) and AI-Driven Business

Patient enrichment & selection for trials

Clinical trial optimization

Via our Helomics subsidiary, we offer a group of clinically relevant,cancer-related tumor profiling and biomarker tests for gynecological cancersthat determine how likely the patient is to respond to various types ofchemotherapy and which therapies might be indicated by relevant tumorbiomarkers.

Skyline Medical - The STREAMWAY System

STREAMWAY System Product Sales

We sell our medical device products directly to hospitals and other medicalfacilities using employed sales representatives, independent contractors anddistributors.

Comparison of three-month periods ended March 31, 2020 and March 31, 2019

Operations expense. Operations expense primarily consists of expenses related toproduct development and prototyping and testing in our current stage.

Liquidity and Capital Resources

Net cash used in operating activities was $2,972,981 and $2,048,653 for thethree months ended March 31, 2020 and March 31, 2019, respectively. Cash used inoperating activities increased in the 2020 period primarily because of theincrease in total operating expense and the additional costs related to theHelomics business.

Liquidity, Plan of Financing, and Going Concern Qualification

We have funded our operations through a combination of debt and equityinstruments including short term borrowings, and a variety of debt and equityofferings.

February 2020 Convertible Note

March 2020 Private Placement of Common Stock and Warrants

March 2020 Amendments to and Extensions of Promissory Notes

April 2020 Paycheck Protection Program

May 2020 Registered Direct Offering of Common Stock and Concurrent PrivatePlacement of Warrants

Off-Balance Sheet Arrangements

We have not engaged in any off-balance sheet activities as defined in Item303(a)(4) of Regulation S-K.

Accounting Standards and Recent Accounting Developments

See Note 1 - Summary of Significant Accounting Policies to the unaudited,Condensed Consolidated Financial Statements of this Quarterly Report on Form10-Q for a discussion of recent accounting developments.

Edgar Online, source Glimpses

Link:
PREDICTIVE ONCOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com

Read More...

The History Of Lynching From Trees: Where did it come from …

June 9th, 2020 9:42 am

Chev

But the Original Jews did NOT challenge Jesus, it was Jews such as the National group that stemmed from a movement prior to the time of Jesus. The Hellene Movement. So, Jesus was challenged by mixed-bred movement of people that were elevated above the Original Jews!!!

Therefore, they were probably telling the truth in that they had never been oppressed in Egypt.

YOU DO NOT UNDERSTAND WHAT THE PROBLEM WAS DURING THAT TIME! Geez!

You shouldn't be so quick to assume what I do and do not understand....lol.

I know there was a struggle between the Sadducees and Pharisees during the time of Jesus.What you're calling the Hellene Movement for the Jews to become more like the Greeks was led by the Pharisees -who were Persian overseers sent to Jersusalem to monitor the Jews when they returned from exile.

The Sadducees (sons of Zadok) wanted to maintain the religion the Moses gave them when he civilized them but the Pharisees wanted to move them more in line with the rest of the Caucasians called Gentiles or Greeks.

Get outta here! That was the book you used as a reference

Go back and look at my quotes.You will find NO QUOTE of me referencing a "Hebrew Standard Version".

I say there is the Hebrew Bible, and the various English translations like King James, American Revised, ect.....

The date of that translation was hundreds of years prior to the scriptures translated just before the time of the CRUSADES, of which became the basis for the

KJV which was translated by Hebrew Israelites.

YOur version is NOT received by Christians today for specific reasons.

But, I will add that I do know some of the terms you referenced is in an Ethiopian version [GEEZ]. But however, scholars today

do NOT agree with those terms for major reasons. and today, the people speak Amharic.

I'm not sure what you mean by "my" version.I don't have too much faith in ANY of them.....lol.But when discussing (or in this case arguing...lol) the Bible I like to get the PURIST source possible to find out exactly what the authors meant, so I usually used the HEBREW Bible.

I haven't quoted from the Hebrew Bible on this site because I have to post the text of it along with the translation and I'm not sure how to do that here.The texts is in both Hebrew and English letters.But that's the one I read from and use the most.

No. The very reference you quoted states that LOT was deceived; he had no idea.

OK?Whether he KNEW it or not, INCEST was still performed!

I said according to the Bible INCEST was commited, I didn't say Lot was willing to do it or started it or loved it or enjoyed it or was tricked into it....I said according to the Bible he DID it.And again, you can't find ANY scriptures where the Kenaani, Kemeti, Sumarian, or other Original peoples committed incest......drunk or sober.

Today, there are numerous findings that attest to the violence in that land byway of the Canaanites. They were BAAL PRIEST, that means HEADHUNTERS

Baal was a Kenaani deityZedek was anotherSalem (of which Jersusalem was named after) was another.

Most of these deities had "priests" or "Kohens" who served them in their dedicated temples.That doesn't mean they were killing people or cutting off heads for them.Melchizedek of the Bible was a Canaanite priest who came out to meet Abraham, was HE a head hunter?

As I told you before, the Kenaani were a very sexual people and this usually means violence was kept to a minimum.What credible source can you reference to say that the priests of Baal were headhunters?

The only record we have of people KILLING others and even chopping off heads (in the case of David) for their "god" are the Israelites who went around slaughtering the Original peoples of the land in the name of Yahweh....according to the Bible.

Read more from the original source:
The History Of Lynching From Trees: Where did it come from ...

Read More...

Bestselling, Award Winning, New and Classic Books for …

June 9th, 2020 9:42 am

Mar/Apr 2020 | Jan/Feb 2020 | Nov/Dec 2019 | Sep/Oct 2019 | Jul/Aug 2019 | May/Jun 2019

Books Coming Out in the Next 6 Months and Beyond Books Published in the Last 60 Days The Most Critically Acclaimed Books of the Past 40 Years Top 150 Recommended African-American Childrens Books More Lists of Books

Bestselling Books for the Year 100 Essential Black Books Top 100 Selling Publisher Imprints Visit our Book Reviews Section 100 Bestselling Books of All-Time The Top 10 Books in 100 Different Categories 100 Bestselling Books of All Time Black-Owned Publishing Companies Favorite 100 Titles of the 20th Century The QBR 100 Essential Black Books Favorite 100 Titles of the 21sth Century (list being compiled now, cast your vote) Go On Girl! Book Clubs Complete Reading List (1991 2020) The Coffee Will Make You Black Book Clubs Reading List (19982006, and 2010) The Power List BestSelling Books (Spring 2013 to Spring 2015) Get Your Book on AALBC.com

We track all of the Black winners of the National Book Awards, Pulitzer Prize, Carter G. Woodson Award, Coretta Scott King Award, and many more. Winners of these awards are factored into our formula for determining The Most Critically Acclaimed Books of the Past 40 Years.

The Coffee Will Make You Black is AALBCs online book club. Check out our reading list and participate in discussions that take place over the course of a month. There is no commitment or pressure; just enjoy.

Link:
Bestselling, Award Winning, New and Classic Books for ...

Read More...

what does it mean to be black – Culture, Race & Economy …

June 9th, 2020 9:42 am

Troy

You are equating Black primarily with skin color, with no real relationship to culture.

Exactly

Still, it is not clear given your definition why Obama is not Black. He is basically the same complexion as I am; am I not Black?

I've seen only limited picturesof you but you don't look Obama's complexion to me.Obama is a light brown complexion and you seem to be medium brown.

Also, his features are different than yours.His lips are thinner and his head is more "angular"....larger dome with a smaller jaw line...like most Europeans.

Like most AfroAmericans I'm sure you're mixed with White and Native American ancestry from way back, but sinceyour African features dominate I consider you Black.You don't have to be 100% just to be of a certain race, just be predominant in those traits.

But Obama's African features don't "dominate".....he's pretty even between both races phenotypically speaking.

Look Troy, the thing we must keep in mind is the fact that while Obama is DIRECTLY mixed....meaing one of his parents is actually White....many so-called "Black" people in the United States are INDIRECTLY mixed. Meaning they have a lot of White (and Native American) ancestry and it comes out in their complexion and facial features just like his does.

So when you point to another AfroAmericans and say:"Well THEY are Black andObama looks like THEM so Obama must be Black too!"

Really, all you're doing is comparing 2 mixed raced people!NEITHER ONE is truly"Black" racially speaking but the only difference is one has an immediateWhite parent and the other has Whites ancestorsfurtherback.

Which leads me to my NEXT response....................

My mother and sister are much lighter than Obama, are they also not Black? Let me know

I don't know, I would have to look at them to make that judgment.As I said before, although complexion/skin color is one of the BIGGEST factors in determining race, it's not the ONLY one....other features go into it.

There are groups of Africans in southern Africa known as San and Khoi people who are YELLOW in complexion with slanted eyes but are still "Black" racially speaking.

Speaking of southern Africa.........

If you're sitting back shaking your head and laughing at what I'm saying -Just remember that in South Africa you have millions of people just like us here in the United States but unlike us they all don't consider themselves "Black".

One group calls themselves Black and the other call themselves "Colored".Now the Coloreds look just like many AfroAmericans, light skinned with curly hair and some European features but they don't consider themselves Black!

So don't trip or think it's so ridiculous at my suggesting that many fellow AfroAmericans like Beyonce or Al B Sure or even Prince shouldn't be considered "Black",if this were any other nation besides the United States....trust me they probably wouldn't consider THEMSELVES Black either!

See the original post here:
what does it mean to be black - Culture, Race & Economy ...

Read More...

Christine Taylor Butler, Author Info, Published Books, Bio …

June 9th, 2020 9:42 am

Writing for children is a joyful endeavor. It takes heart, passion, and one endearing story that yearns to be told. As with all things, commit to putting your own ideas on paper. A story left untold will never blossom or touch the heart of a reader. Christine Taylor Butler

Christine Taylor Butler grew up in Ohio surrounded by books and literature. She developed an overwhelming passion for reading and writing at an early age that defined her purpose and who she has become today. She read every opportunity that she got and even made up story filled adventures of her own. Sadly even though she was a gifted and prolific writer she was missing one ingredient in order to step out on her dreams of becoming a writer, and that was courage. Fear gripped her heart and to alleviate the fear of stepping out she became preoccupied with other productive tasks. Some entail a New England boarding school, two MIT degrees (Engineering and Art & Design)and a series of jobs that included working for a start-up software company. Following thereafter was several years at Harvard University and more than a decade as a Graphic Arts Manager at Hallmark Cards. Although she was productive the overwhelming desire to write kept knocking on the doors of her heart until she eventually opened up.

One of the main reasons for her courageously stepping out in pursuit of a career as an author was the love that her two daughters had for reading childrens books. But it saddened her to see their urban peers did not. She came to the conclusion that sadly multicolored children dont see themselves as being relevant in todays society or as having the potential to make a difference. And even though more books are now like never before presenting children of color in a more positive light Christine wanted to really ensure that this continued. As a result of her lending her voice and being an agent of change her writing career soared. Since then she has released 65 commercially published books.(2018)

Christine Taylor Butler is a force to be reckoned with. She genuinely enjoys the journey of childrens book writing and prides in the fact that she was courageous enough to answer the call to write. She has received a countless amount of awards, ranging from Best Childrens Book of the year by Bank Street College Of Education. Best Books Of The Year by Nebraska Library Association, Best Childrens Book of the year by Barnes and Noble Review. As well as Best Multicultural Books list just to name a few. Her accolades attest to the fact that writing, inspiring and captivating the hearts of children through writing is what she was destined to do.

Author profile written by Daisy Copelin.

Are you the author profiled here? Email us your official website or Let us host your primary web presence.

Tell us how much you like Christine Taylor Butler.

See the original post here:
Christine Taylor Butler, Author Info, Published Books, Bio ...

Read More...

New Genetic Identification of COVID-19 Susceptibility Will Aid Treatment – SciTechDaily

June 9th, 2020 9:42 am

The clinical presentation of Covid-19 varies from patient to patient and understanding individual genetic susceptibility to the disease is therefore vital to prognosis, prevention, and the development of new treatments.

For the first time, Italian scientists have been able to identify the genetic and molecular basis of this susceptibility to infection as well as to the possibility of contracting a more severe form of the disease. The research will be presented to the 53rd annual conference of the European Society of Human Genetics, being held entirely on-line due to the Covid-19 pandemic, today [Saturday].

Professor Alessandra Renieri, Director of the Medical Genetics Unit at the University Hospital of Siena, Italy, will describe her teams GEN-COVID project to collect genomic samples from Covid patients across the whole of Italy in order to try to identify the genetic bases of the high level of clinical variability they showed. Using whole exome sequencing (WES)[1] to study the first data from 130 Covid patients from Siena and other Tuscan institutions, they were able to uncover a number of common susceptibility genes that were linked to a favorable or unfavorable outcome of infection. We believe that variations in these genes may determine disease progression, says Prof Renieri. To our knowledge, this is the first report on the results of WES in Covid-19.

Searching for common genes in affected patients against a control group did not give statistically significant results with the exception of a few genes. So the researchers decided to treat each patient as an independent case, following the example of autism spectrum disorder. In this way we were able to identify for each patient an average of three pathogenic (disease-causing) mutations involved in susceptibility to Covid infection, says Prof Renieri. This result was not unexpected, since we already knew from studies of twins that Covid-19 has a strong genetic basis.

Although presentation of Covid is different in each individual, this does not rule out the possibility of the same treatment being effective in many cases. The model we are proposing includes common genes and our results point to some of them. For example, ACE2 remains one of the major targets. All our Covid patients have an intact ACE2 protein, and the biological pathway involving this gene remains a major focus for drug development, says Prof Renieri. ACE2 is an enzyme attached to the outer surface of several organs, including the lungs, that lowers blood pressure. It serves as an entry point for some coronaviruses, including Covid-19.

These results will have significant implications for health and healthcare policy. Understanding the genetic profile of patients may allow the repurposing of existing medicines for specific therapeutic approaches against Covid-19 as well as speeding the development of new antiviral drugs. Being able to identify patients susceptible to severe pneumonia and their responsiveness to specific drugs will allow rapid public health treatment interventions. And future research will be aided, too, by the development of a Covid Biobank accessible to academic and industry partners.

The researchers will now analyze a further 2000 samples from other Italian regions, specifically from 35 Italian Hospitals belonging to the GEN-COVID project.[2]

Our data, although preliminary, are promising, and now we plan to validate them in a wider population, says Prof Renieri. Going beyond our specific results, the outcome of our study underlines the need for a new method to fully assess the basis of one of the more complex genetic traits, with an environmental causation (the virus), but a high rate of heritability. We need to develop new mathematical models using artificial intelligence in order to be able to understand the complexity of this trait, which is derived from a combination of common and rare genetic factors.

We have developed this approach in collaboration with the Siena Artificial Intelligence Lab, and now intend to compare it with classical genome-wide association studies[3] in the context of the Covid-19 Host Genetics Initiative, which brings together the human genetics community to generate, share, and analyze data to learn the genetic determinants of COVID-19 susceptibility, severity, and outcomes. As a research community, we need to do everything we can to help public health interventions move forward at this time.

Chair of the ESHG conference, Professor Joris Veltman, Dean of the Biosciences Institute at Newcastle University, Newcastle upon Tyne, UK, said: We are very excited to have this work on the genetics of COVID19 susceptibility presented as one of our late-breaking abstract talks at the ESHG. Our Italian colleagues present the first insight into the role of genetic susceptibility influencing the severity of the response to a COVID19 infection. It needs to be expanded to encompass much larger populations, but it is impressive to see the speed at which research on this virus has proceeded in just a few months time.

Originally posted here:
New Genetic Identification of COVID-19 Susceptibility Will Aid Treatment - SciTechDaily

Read More...

Do you have the rocket gene? Why genetics may decide whether you like the peppery veggie – The Independent

June 9th, 2020 9:42 am

Love it or hate it, rocket is popular all over the world. Also known as arugula, roquette and rucola, its known for its pungent and peppery flavours. It might look like an unassuming leafy vegetable, but the reasons for its taste, health benefits and whether we like it all comes down to genetics.

Rocket actually encompasses several species, all of them part of the same family as broccoli, cabbage, kale, mustard and watercress the Brassicales. Its distinctive aroma and flavours are created by chemical compounds produced by its leaves, called isothiocyanates. Some of these compounds can be eye-wateringly hot, whereas others can have a radishy flavour or none at all.

In the wild, isothiocyanates are thought to help defend plants from herbivores and disease, and also help it tolerate environmental stress. But for humans, eating isothiocyanates confers health benefits. Studies have shown them to have anti-cancer properties, and anti-neurodegenerative effects against diseases such as Alzheimers.

Sharing the full story, not just the headlines

For this reason, plants containing isothiocyanates interest scientists particularly those with little taste and flavour. One such compound is sulforaphane, which is found in rocket and broccoli. Several years ago, researchers produced a super broccoli with high amounts of sulforaphane. Consumers couldnt taste the difference, and it was later shown to be effective in preventing and slowing prostate cancer and in lowering cholesterol.

But one advantage with rocket is that it doesnt need cooked to be eaten. Heating other Brassicales, like broccoli, to over 65C inactivates myrosinase, which is an enzyme in their tissues that converts compounds called glucosinolates into sulforaphane and other isothiocyanates when people chew these plants. If the myrosinase is inactivated, consumers will receive little or none of the associated health benefits, no matter how much is bred into the plants.

Chewing aside, theres some evidence to suggest that our gut microflora possess their own myrosinase and can convert glucosinolates to isothiocyanates for us. The amounts this produces are likely to be quite small, but release may be sustained, exposing our cells to compounds like sulforaphane for longer periods.

But the biggest barrier to people getting these beneficial molecules from rocket is the taste. This depends on when and where rocket crops are grown. In the summer, leaves can be extremely spicy and pungent, whereas in the winter they can be bland and tasteless.

There are many different varieties of rocketiStock)

Growth temperature likely plays a big role in determining the amounts of isothiocyanates released from leaves. Probably a stress response by the plants, it means hotter countries like Italy may produce more pungent leaves.

You can test this effect at home. Get two small pots and some rocket seeds from a local garden centre or supermarket. Plant two or three seeds in each. Keep one well-watered and relatively shaded, and the other in direct sunlight, watering infrequently. After a few weeks, taste the leaves from each pot one should taste much hotter.

The taste and flavour of rocket also varies because of the genetics of different varieties. Not only do leaves contain hot, pungent isothiocyanates, but also sugars (which create sweetness); pyrazines (which can smell earthy and pea-like); aldehydes (which smell like grass); alcohols (one in particular smells just like mushrooms); and many other types yet to be identified.

Recently, the worlds first rocket genome and transcriptome sequence was produced from the Eruca sativa species, allowing researchers to understand which genes may be responsible for making the compounds related to taste and flavour. Its genome contains up to 45,000 genes, which is more than the 42,611 genes humans are thought to have.

The research also found that different varieties produce more isothiocyanates and sugars than others. This explains why leaves can taste so different in the supermarket, even when bought from the same shop at the same time of the year. By knowing which genes are expressed in tissues and when, we can select rocket plants with improved taste and flavour profiles and breed new and improved cultivars.

To further complicate matters, our own genetics mean we dont all taste chemical compounds the same. We have many thousands of different odour receptors in our brains, and many different combinations of taste receptors on our tongues. These genetic differences are one of the reasons why coriander tastes different to different people. Those with a variant of the OR6A2 gene perceive the leaves as having a soapy flavour, which is thanks to the aldehyde compounds in coriander that activate this receptor variant.

Depending on whether you have a functioning or non-functioning copy of certain taste receptor genes, you may not be able to taste certain compounds at all. In the other extreme, if you have two working copies of a particular gene, some foods may taste unbearably bitter and unpleasant.

Another classic example is Brussels sprouts. Some people love them, while others loathe them. This is because of the gene TAS2R38 which gives us the ability to taste the bitter glucosinolate compounds in these vegetables as well as rocket.

Love or loathe? The superfood continues to divide (iStock)

Those people with two working copies of the gene are bitter supertasters. People with only one are medium tasters, while those with no working copies are blind to these compounds. So what is intense and inedible to one person might be pleasant and mild to another.

This partly explains peoples general food preferences and rocket leaves are an excellent example of these processes in action. A consumer study of rocket leaves showed that some people like them hot and pungent, others like them sweet and mild, and others just dont like them at all.

However, peoples culture and life experience probably also determine whether they like rocket and other foods. A previous study of rocket showed that peoples genetic differences are not necessarily an indicator of whether they will like something. Its perfectly possible to be a bitter supertaster and like rocket and Brussels sprouts depending on your upbringing and exposure to them.

Another study showed that preference for flavour and pungency of white radish is linked to differences in geography and culture. Japanese and Korean people liked pungency created by an isothiocyanate much more than Australians. Pickled radish is a common condiment in Asian countries: being regularly exposed to a food may predispose people to like it, irrespective of their taste sensitivity.

Very little is currently known about the interactions between plant and human genotypes. But ongoing research aims to find out which compounds people with different TAS2R38 genotypes are sensitive to. This will make it possible in the future to selectively breed in (or out) certain genes, and produce rocket types tailored to a persons preferences.

Luke Bell is a lecturer in temperate horticulture at the University of Reading. This article first appeared on The Conversation

View post:
Do you have the rocket gene? Why genetics may decide whether you like the peppery veggie - The Independent

Read More...

Deep exploration of the genetic dependencies of antibiotic function on SelectScience – SelectScience

June 9th, 2020 9:42 am

Massively parallel microbial strain engineering on a CRISPR-based benchtop platform has enabled the exploration of the genetic dependencies of antibiotic function in unprecedented scale and detail. The ability to design and deliver precisely determined edits throughout the entire E. coli genome has resulted in an unparalleled opportunity to query a diverse population of strain variants for their growth responses to antibiotics from multiple different functional classes.

Find out more in this expert webinar as Dr. Dan Held, Director of Synthetic Biology, Microbial Applications Development, Inscripta, outlines how the knowledge garnered through the use of this strain engineering technology has significant potential to lead to the development of novel therapeutics against our most difficult antibiotic-resistant pathogens.

Key learning objectives

Who should attend?

Certificate of attendance

All webinar participants can request a certificate of attendance, and a learning outcomes summary document for continuing education purposes.

View post:
Deep exploration of the genetic dependencies of antibiotic function on SelectScience - SelectScience

Read More...

Expert Insight: Discover the genetic dependencies of antibiotic function – SelectScience

June 9th, 2020 9:42 am

Join us on Friday, June 19, to find out how massively parallel microbial strain engineering may lead to the development of novel therapeutics to combat the most difficult antibiotic-resistant pathogens

Massively parallel microbial strain engineering on a CRISPR-based benchtop platform has enabled the exploration of the genetic dependencies of antibiotic function in unprecedented scale and detail. The ability to design and deliver precisely determined edits throughout the entire E. coli genome has resulted in an unparalleled opportunity to query a diverse population of strain variants for their growth responses to antibiotics from multiple different functional classes.

Find out more in this expert webinar as Dr. Dan Held, Director of Synthetic Biology, Microbial Applications Development, Inscripta, outlines how the knowledge garnered through the use of this strain engineering technology has significant potential to lead to the development of novel therapeutics against our most difficult antibiotic-resistant pathogens.

Key learning objectives

Who should attend?

This webinar will run on Friday, June 19, 2020, at:

Register to watch the full webinar here>>

SelectScience runs 3-4 webinars a month across various scientific topics,discover more of our upcoming webinars>>

Read the original post:
Expert Insight: Discover the genetic dependencies of antibiotic function - SelectScience

Read More...

‘We could have waves of infection, waves of lockdown’ says professor of genetics – Irish Examiner

June 9th, 2020 9:42 am

A professor of genetics has warned that there is every possibility of a resurge in Covid-19 and that Ireland could be facing waves of infection and waves of lockdown.

Professor David McConnell of Trinity College, Dublin called for a vigorous, centralised testing system on a massive scale similar to that employed in South Korea.

Speaking on RT radios Today with Sarah McInerney show he said: People think we're out of the woods, it's really quite dangerous. Today we are in the same position as we were on 12th March. What happened on that date - we went into an epidemic. Everything is there for us to resurge to have an equally vigorous epidemic. We could have waves of infection, waves of lockdown.

Prof McDonnell said that the authorities in Ireland should not be happy with what they have done to date.

They say that they have the capacity for 15,000 tests a day, they say they're only using 5,000 - I think there's something quite strange going on. One of the most remarkable things is we don't have a strongly organised, highly centralised, very effective, very fast tracing system or testing system.

We have a distributed system - essentially people in ordinary hospital labs have been repurposed and reassigned to work on the coronavirus testing, this is not what the Koreans had, they had this massive highly centralised, dedicated system, focused on coronavirus.

Our's is adequate for what it is being used for, but it is a very, very weakly organised system, such that it cannot be applied to other major tasks which I suggest it should be applied to.

Prof. McDonnell said he would suggest three measures first the introduction of a really vigorous test and tracing system where contacts could be tracked and traced within a day this would eliminate community-based cases, he said.

Secondly, assuming there was a well-managed system in place then there should be testing of all incoming visitors at all ports. We should have the ability to test all people coming into the country.

His third suggestion was, if there was a large capacity testing system in place then all educational and care facilities (including creches, schools and universities) could reopen if all teachers, carers and children are tested.

There was nothing in place at present he said to even consider this. If we had decided months ago, which we didn't, that we would generate a terrifically powerful testing system, today we would have been able to imagine re opening schools, easily, by September.

You'd do it in stages and you'd have a capacity which would allow you to open the schools and they would be opened under normal circumstances - no question of half of the children in a class coming in the morning, half in the afternoon, and so on.

Prof. McDonnell said that such a system could be in place by September, but it would take a massive administrative policy decision such as establishing a new testing and tracing agency which would be located on a single site, such as IDA factory.

The cost will be a very small price to pay if the prize at the end is the reopening of our economy on a normal basis.

We are running up expenses at the moment of billions of euros - the cost of a massive testing agency set up very quickly would be miniscule, a fraction of the cost which we are bearing at the present time and are likely to continue as our society and economy stutter along into the foreseeable future until a vaccine becomes available and is massively deployed around the country.

My own worry is that each time we introduce a relaxation there will be a minor, or maybe a major surge of the virus and the reaction of our authorities will be to reimpose stricter lockdown regulations, so we'll go up and down, up and down and it will be very frustrating, schools will not be reopening on a normal basis which is a terrible imposition on children and their parents.

Imagine the disappointment in September when we don't have ordinary care facilities open, ordinary creches, ordinary schools, we've put up with it until now, the incredible weather has helped, we've been stoic, people have been absolutely wonderful.

View original post here:
'We could have waves of infection, waves of lockdown' says professor of genetics - Irish Examiner

Read More...

South Australian photographer snaps rare black galah with genetic mutation on the Eyre Peninsula – ABC News

June 9th, 2020 9:42 am

A rare sighting of a galah with a genetic mutation has been snapped by photographer Hoss Bolenski in Port Lincoln, South Australia.

The galah, which is usually grey and pink in colour, was seen at North Point Reserve covered in black feathers with a tinge of pink on its underbelly.

Bird Life Australia coordinator and science writer, Tanya Loos, said the unique colouring is due to a mutation called melanism, which causes an increased development of a dark-coloured pigment.

"The variation that happens in this colour abnormality is really interesting," Ms Loos said.

"Sometimes the bird is completely black and other times it's more of a flush, or a patterning where some parts are darker than usual."

Ms Loos said melanism in galahs is quite rare, making it hard to conduct broad studies on their patterns and behaviours.

"There is some idea that maybe it's a bit harder for them to find a mate, because birds attract each other not only by their behaviours, but also by their beauty and brightness of their feather colours," she said.

"If a galah is looking for a mate and looking for a galah with a really nice bright, pink blush and a deep grey colour the black bird might just seem a little bit out of the ordinary."

In Manjimup, Western Australia, a rare sighting of a black kookaburra with melanism excited bird experts who found little evidence of the bird ever being spotted in WA.

Birds can also display another genetic mutation called 'leucism' where their feathers are completely white.

"Bird Life Australia get enquiries and emails about the white birds much more commonly because leucism happens in a really wide variety of birds including honey eaters and magpies," Ms Loos said.

In 2018, a magpie with leucism was spotted in the Flinders Ranges, South Australia.

"These birds stand out like a beacon and they often get eaten by predators very quickly," Ms Loos said.

She said research suggested birds that are coloured black may have a better advantage when it comes to survival.

"They do note that sometimes the birds that are coloured black are more camouflaged, so it might be an advantage," Ms Loos said.

"But because it happens so rarely in nature it's hard to conduct broad studies on this and get some actual definitive answers."

See the original post:
South Australian photographer snaps rare black galah with genetic mutation on the Eyre Peninsula - ABC News

Read More...

BBC edits article on Putins daughter overseeing genetic research project following clarification from Rosneft – Meduza

June 9th, 2020 9:42 am

The BBC Russian Service has edited its article on Putins alleged eldest daughter, pediatric endocrinologist Maria Vorontsova, partnering with Russian energy giant Rosneft to create a new genetic research center in Moscow.

The new version of the article now under the headline Rosneft became a partner in a large-scale Russian genetic project removes claims that Maria Vorontsova and Rosneft CEO Igor Sechin will sit on the new centers board of directors. Mention of Rosneft investing between $500 million and $1 billion in the project has also been removed.

The BBC notes that the aforementioned information was deleted on the basis of clarification on the part of Rosneft, received after the articles publication. The inclusion of this information did not meet the required standards for publication, the statement says.

The names of the journalists who worked on the report have also been removed from the article.

Immediately after the article in question was published, Rosneft said that it contains a baseless lie regarding the company and individuals not involved in the given project. The companythreatened the BBC with a lawsuit, as well.

The rest is here:
BBC edits article on Putins daughter overseeing genetic research project following clarification from Rosneft - Meduza

Read More...

Human Genetics Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 – Cole of Duty

June 9th, 2020 9:42 am

A new market report by Market Research Intellect on the Human Genetics Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Human Genetics sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=177432&utm_source=COD&utm_medium=888

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Human Genetics manufacturers/companies operating at both regional and global levels:

Sales and sales broken down by Product:

Sales and sales divided by Applications:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Human Genetics Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=177432&utm_source=COD&utm_medium=888

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Human Genetics. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Market Research Intellect

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=177432&utm_source=COD&utm_medium=888

Customization of the Report:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Human Genetics market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

View original post here:
Human Genetics Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 - Cole of Duty

Read More...

How a rare bird and the coronavirus remind us that our safety depends on sciencenot wishful thinking – Genetic Literacy Project

June 9th, 2020 9:42 am

There are worse places to spend a COVID-19 lockdown than next to a sanctuary with one of the worlds rarest birdsthe New Zealand takah. And during this strange moment in history, its wonderful to watch these remarkable relics from the pasttakah were twice declared extinct and twice rebounded unexpectedly from the deadin the shadow of their last wild refuge, the Murchison Mountains in Fiordland National Park.

Indeed, these colorful swamphens and the coronavirus pandemic both exemplify opposite extremes of widely held beliefs about the natural world; attitudes towards nature, moreover, that reflect much popular misunderstanding about evolutionary biologyand genetics in particular.

Given this, the much-regarded bird and the much-reviled virus can usefully illustrate some of the important contradictions and confusions that befuddle broader public appreciation of modern genetic science. So lets begin with a little more detail about the former, the amusingly clumsy-looking takah, the worlds largest rail.

Well-known in pre-contact times to New Zealands indigenous Maori, takah were initially thought extinct by the first European scientists to examine their fossilized remainsan assessment that proved mistaken when a small number of these flightless rails were caught during the latter part of the 19th century, the last in 1898.

Presumed extinct (for the second time) for the following fifty years, takah were famously rediscovered in the rugged and remote Fiordland mountains in 1948an event that triggered both an international avalanche of publicity and intense debate about how best to protect the last remnants of the species. Today considered a national taonga or treasure, this cherished bird is now a darling poster child for New Zealand conservation.

They are also, by all accounts, extremely tastyearly Maori hunted them extensively as a source of much-prized feathers and food, and the sealers who caught and cooked one in 1850 declared it a most delicious dainty.

This then raises a question that is less facetious than might first appear: Would it be okay to eat a takah? And if not, why not? Here we can start to explore the popular beliefs about nature alluded to above, ones that result in wider uncertainty about modern genetic science and, at an extreme, vocal opposition to genetic modification and genetic engineering.

To many nature-lovers, even talking about eating an animal like the takah would likely seem immoral; after all, these birds (like other endangered species everywhere, from black rhinos to gorillas to whales) are special. Yet if we examine this belief, being special appears to amount to little more than being rare. Nor could being wild be a cause for special status; this implies, for instance, that captive-bred rare animals are of less value than their free-living counterparts.

Yet while it is rationally unclear (independent of scarcity) why wild animals should have greater intrinsic value than farmed ones, it is nevertheless a distinction that many people maketreasuring rare or wild animals over well-known domesticated ones. (This inconsistency in attitudes is also evident in the furor over the euthanizing of a single giraffe in 2014 in a zoo in Denmark, an agricultural country where tens of thousands of farm animals are routinely slaughtered each day.) If takah were as common as chickens, sayor whales as widespread as cowswould they still be seen as special?

The old adage familiarity breeds contempt is also evident in antipathy towards genetically modified foods. That is, in the same way that familiar livestock are overlooked in comparison with wild/rare animals, so too are supposedly natural everyday foodstuffs in the vehement rejection of unnatural genetically adulterated Frankenfoods. In reality, of course, all of our staple crops have themselves been genetically modified through selective breeding over time, with manyincluding such common items as corn, peaches and watermelonsveritable monstrosities compared to their wild precursors.

Furthermore, such unexamined beliefs about what is natural and what is unnatural help explain how support for wildlife conservation can morph into opposition to genetic sciencemost especially, in the idea that human activities destroy the delicate balance of nature. Despite having been long-since rejected by ecologists, the romanticized concept of a natural balanceanthropomorphised as a wise and benign Mother Nature, constantly striving to maintain the natural harmonystill holds sway in public consciousness.

A surprising example of this concept of purpose and harmony in nature is Pope Franciss recent suggestion that COVID-19 is natures response to climate change. While the Pope is an odd source for such a claim (after all, traditionally God is the one who directs plagues for His own purposes, as many believers still insist), it is nevertheless based on the same belief in a natural (or supernatural) guiding force maintaining natures equilibrium in a world bespoilt by humankind.

Such a notion, of course, stands in stark contrast to the Darwinian concept of life, in which the illusion of harmony merely masks a precarious stalemate in the ceaseless competition between and among species. Moreover, the evolutionary view regards nature as purposeless and amoral, with the ultimate aim of living organisms being simply survival and replication.

In which case, COVID-19 is not natures revenge (or Gods wrath), but rather the mindless spread of an incredibly successful sequence of genes, a contagious virus replicating at the expense of other organisms that just happen to be us. Plagues and pestilence, in other words, are as much a part of nature as wonderful animals like the takah (a point humorously made in Monty Pythons All things dull and ugly).

Potentially, the current coronavirus crisis may disabuse many people of their romanticized notions about benevolent and harmonious nature; at any rate, the overwhelming world reaction is not simply to let nature take its course but rather to act to mitigate its worse effects. And while the unexpectedness and novelty of the pandemic has left many nations floundering over how best to respond, the ultimate solution(s) can only be derived from evidence and factsin other words from empirical science. At the same time, however, the fight against COVID-19 will likely be hindered by the very things that dog the rational application of genetics to human needsmisinformation, conspiracy thinking and pseudo-science.

But before drawing the disparate threads of this argument together, lets return to the takah, itself an excellent example of the pitiless Darwinian account of life. Like much of New Zealands avian fauna, the takahs ancestors were accidental, wind-blown arrivals on these remote South Pacific islands. Lacking competition in their new environment, takah numbers rapidly expanded while at the same time evolutionary processes, including island gigantism, gradually morphed them into the large, flightless and slow-breeding animals we see today. And, like numerous other New Zealand species, the takah were therefore easily out-competed by the next set of arrivals, the fast-breeding mammals introduced by human beings.

Yet while the ensuing tidal wave of bird extinctions was initially viewed as natural and inevitable, modern attitudes have changedand now New Zealands conservation efforts are directed at preserving the surviving native species by eradicating the more recent mammalian invaders. A tragic irony here is that, in the name of conservation, many native species are kept alive only through the mass killing of exotics.

Further ironies abound. Reassured by evidence-based science, the majority of New Zealanders accept the use of 1080 sodium monofluoroacetate poison as the most effective means to control pest speciesyet at the same time, research into more humane genetic alternatives (such as the use of gene drives) are stymied by the countrys vocal anti-GMO movement and its dated and restrictive legislation on genetic technology.

Indeed, the emotional, anti-scientific hostility to 1080 poison captures many of the points raised above, most especially in the belief that native and introduced species can coexist in a natural equilibrium (a notion belied by the estimated 25 million native New Zealand birds killed by introduced predators each year).

As for the takah itself, an initial willingness to let nature take its course was a factor in the species calamitous decline to just over 100 individuals by the 1980s, before more scientifically guided (and better funded) conservation policies began to take effect. Genetics has since played a strong part in hauling the takah back from the brink of extinction, particularly in mitigating the damaging effects of in-breeding. Genetic research has also uncovered surprising findings about the takahs origins; originally divided into two subspeciesone in New Zealands North Island and the other in the South Islandmore recent genetic analysis suggests these were instead two separate species, with the extinct northern variety descended from Australian swamphens and the extant southern species more closely related to South African rails. (Convergent evolution explains the physical similarities between the distinct species on either island.)

And here, takah genetics can usefully illustrate a final point about our conceptions (and misconceptions) of the natural world. Those most attracted to idealized visions of nature (and hence prey to anti-science attitudes), often assume that science robs nature of its glory and wonder. In fact it does the opposite; the more we understand about animals such as the takah (or indeed viruses such as SARS-cov-2), the more we are able to marvel at the wonders of evolved creation. And while romantic wishful thinking wont save the tasty takah from extinction (nor us humans from COVID-19), modern science just might.

Patrick Whittle has a PhD in philosophy and is a freelance writer with a particular interest in the social and political implications of modern biological science. Follow him on his website patrickmichaelwhittle.com or on Twitter @WhittlePM

Read more from the original source:
How a rare bird and the coronavirus remind us that our safety depends on sciencenot wishful thinking - Genetic Literacy Project

Read More...

Genetic editing of grapes by CRISPR could reduce the use of pesticides in Europe – FreshPlaza.com

June 9th, 2020 9:42 am

The cultivation of grapes in Europe, whose acreage represents 3% of the total cultivable acreage, accounts for up to 65% of the pesticides used by EU growers, given the high incidence of powdery mildew and mildew in the productions. However, this percentage could be drastically reduced if the EU opted for the most advanced plant reproduction technologies, such as CRISPR, which would make it possible to obtain grape varieties resistant to both fungi.

Thus, research has been carried out in this field for several years in order to improve European grape varieties. In the case of Italy, in 2015, ten genetically edited grape varieties were registered in the National Variety Catalog, and in 2018, the first field harvests were carried out. Although still in the pre-commercial phase, the results so far have been positive in terms of resistance to diseases.

The researchers hope that the regulatory uncertainty of CRISPR technologies will be resolved (they are subject to the same regulations as transgenics, despite not being the same). They also hope that both producers and consumers will learn about the potential of these techniques to tackle the agro-food and environmental challenges that humanity is facing.

Source: agronewscastillayleon.com

The rest is here:
Genetic editing of grapes by CRISPR could reduce the use of pesticides in Europe - FreshPlaza.com

Read More...

Page 534«..1020..533534535536..540550..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick